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.Sno4ta*UHe*t&il ALERT....
R / l  Trichloroethylene (TCE) is a common industrial solvent and contaminant o f hazardous 
-----*--waste sites, groundwater, and drinking water.
[ \ J | TCE is a CNS depressant and a suspected hepatotoxin in humans.
| \ J | EPA considers TCE an animal carcinogen and a potential cancer hazard to humans.
This monograph is one in a series o f self-instructional publications designed to increase the primary care 
provider's knowledge o f hazardous substances in the environment and to aid in the evaluation o f potentially 
exposed patients. The Agency for Toxic Substances and Disease Registry (ATSDR) and the Centers for 
Disease Control (CDC) designate this continuing medical education activity for 1 credit hour in Category 1 of 
the Physician's Recognition Award o f the American Medical Association and 0.1 continuing education units for 
other health professionals. See pages 21 to 23 for further information.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each 
section. To fully benefit from this monograph, readers are urged to answer each question when it is presented. 
(Answers to the Pretest and Challenge questions are found on pages 19-20.) The monograph ends with a posttest, 
which can be submitted to ATSDR for continuing medical education (CME) credit or continuing education units 
(CEU). See page 21 for further instructions on how to receive these credits.
The objectives of this monograph on trlchloroethylene are to help you:
□  Realize why trlchloroethylene Is an acute and chronic health hazard
□  Understand the known factors contributing to trlchloroethylene toxicity
□  Assess a patient's environmental or occupational exposure to 
trlchloroethylene
□  Effectively evaluate and manage trlchloroethylene-exposed patients
□  Utilize a variety of sources to locate further information on trlchloroethylene
This issue is prepared with the assistance of those who share a common concern for physician education, public 
health, and the environment, including the following organizations: American Academy of Family Physicians 
(AAFP), American Academy of Pediatrics (AAP), American College of Emergency Physicians (ACEP), American 
College of Occupational Medicine (ACOM), American Medical Association (AMA), Association of State and 
Territorial Health Officials (ASTHO), and the Society of Teachers of Family Medicine (STFM). Final responsibility 
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Trichloroethylene toxicity
Concerns of a young family exposed to TCE-contaminated drinking water
Your practice is in a suburban community with a number of high-technology industries. A couple for whom 
you have been the family physician asks for an appointment to discuss their daughter’s illnesses and a 
matter of concern to them.
During the initial consultation, the mother reports that they are living in an area supplied by municipal well 
water. They have recently received a notice from the municipal water district stating that their drinking water 
contains 100 parts per billion (ppb) trichloroethylene (TCE), and as a precaution, they are being supplied 
with bottled drinking water until an alternative well can be put into service. The notice indicates that the well 
water is suitable for bathing and laundering. The father interjects that he is familiar with TCE; it is used in 
the electronics plant where he works.
The daughter, aged 4, has had a number of ear infections during her first 2 years, culminating in a 
myringotomy at age 3. Follow-up by an ENT specialist has shown normal hearing. Although there have been 
no further infections, the mother stresses that her daughter seems to have a greater number of colds than 
her classmates and “has not seemed as healthy as she should be.” However, the daughter's chart does not 
reflect an unusual number of office visits or calls. The mother also notes that the child’s day-care center 
is next to “some kind of machine shop” where a chemical odor has been noticed recently. Several of the 
children and one of the teachers have complained of eye and throat irritation in association with the odor.
The mother, who is 33 years old, then reveals that she may be pregnant and she has had mild nausea for 
1 week. It has been 8 weeks since her last menstrual period. Both parents are concerned about the 
possibility that the TCE in the drinking water might have affected the fetus. Although this pregnancy was 
planned, they might consider terminating the pregnancy if the baby was likely to be “damaged.” They are 
also concerned that the entire family might suffer from cancer or other diseases in the future.
Before receiving bottled water, the family drank tap water when thirsty and made coffee with tap water. Tap 
water also was used for cooking and brushing their teeth, and is still used for bathing. They have never 
noticed discoloration or an off-taste to the tap water. They encourage their child to drink water instead of 
sodas during the summer and estimate the amount of water each of them consumes is 2 to 3 glasses a day.
You schedule each parent and the child for an individual office visit.
(a) What would you include in the mother's and daughter's problem list?
(b) What additional information would you seek before seeing the family again?
(c) What reassurances might you provide at the end of this in itia l visit?





The odor threshold of TCE is 
20 to 80 ppm, which may not 
provide adequate warning of 
toxic levels.
The most common sources 
of nonoccupatlonal exposure 
to TCE are ambient air and 
drinking water.
Trichloroethylene or TCE (CI2C=CHCI) is a clear, colorless, 
nonflammable liquid possessing a sweet, fruity odor character­
istic of chloroform. The odor threshold is approximately 20 to 
80 parts per million (ppm). For some workers, TCE’s odor may 
not be detectable at concentrations near the permissible workplace 
exposure limit of 50 ppm (as determined by an 8-hour time- 
weighted average), and so may not provide adequate warning of 
its presence.
The official chemical name of trichloroethylene is trichloroethene. 
Other synonyms include TCE, TRI, acetylene trichloride, and 
ethylene trichloride. Trade names for this industrial solvent 
include Benzinol, Circosolve, Flock Flip, Narcogen, Perm-A- 
Chlor, Tri-clene, and Vestrol.*
TCE does not occur naturally; therefore, its presence indicates 
manufacture, use, or storage. Eighty percent of TCE is used for 
vapor degreasing of fabricated metal parts in the automotive and 
metal industries. Consumer products that contain TCE include 
typewriter correction fluids, paint removers/strippers, cosmet­
ics, adhesives, spot removers, and cleaning fluids for rugs. Prior 
to its ban for certain applications in 1977, TCE was also used as 
a general (mostly obstetrical) anesthetic, analgesic, grain fumi­
gant, disinfectant, pet food additive, and extractant of spices in 
foods and caffeine in coffee.
Occupational exposures may occur in chemical industries that 
manufacture polyvinyl chloride, pentachloroethane, and other 
polychlorinated aliphatic hydrocarbons, flame retardant chemi­
cals, and insecticides. Other potential exposures occur in manu­
facturing processes of disinfectants, pharmaceuticals, dyes, 
perfumes, and soaps. Mechanics, oil processors, printers, resin 
workers, rubber cementers, shoe makers, textile and fabric 
cleaners, tobacco denicotinizers, varnish workers, and dry clean­
ers also have increased likelihood of TCE exposure, although 
most dry cleaners now use tetrachloroethylene (perchloroeth- 
ylene) or 1,1,1-trichloroethane.
In the workplace, TCE is seldom present as a pure substance, 
industrial grade TCE contains small amounts of stabilizers in the 
form of antioxidants or acid receptors; total chemical impurities 
usually do not exceed 0.1% by weight. Decomposition of TCE 
into dichloroacetylene (a neurotoxic compound) and phosgene
* Use of trade names is for identification only and does not imply endorsement 




(a serious pulmonary irritant) occurs in the presence of alkali at 
temperatures above 60°C for the unstabilized compound and 
above 130°C for the stabilized compound.
Because of its widespread use, TCE has become a common 
environmental contaminant. Contamination results from evapo­
rative losses during use; discharge to surface waters and ground­
water by industry, commerce, and individual consumers; leach­
ing from hazardous waste landfills into groundwater; and from 
the incidental addition of TCE during food production.
In the atmosphere, TCE is destroyed by photooxidation, with a 
half-life of less than 7 days. This relatively short half-life signifi­
cantly limits the transport of TCE in air; however, the continual 
volatilization of TCE from emission sources or contaminated 
surface waters ensures its persistence in air. Examination of 
arctic air between 1982 and 1983 demonstrated mean TCE 
levels of 8 to 9 parts per trillion (ppt). This compares to mean 
concentrations of 30 ppt TCE in rural or remote areas, 460 ppt 
in urban and suburban areas, and up to 1200 ppt in areas 
nearest emission sources. Surveys have detected TCE in at 
least 460 of 1177 hazardous waste sites on the U.S. Environ­
mental Protection Agency’s (EPA) National Priorities List, with a 
maximum level of 12,300 ppt TCE in the ambient air at one New 
Jersey site.
TCE in drinking water is a result of its rapid leaching from landfills 
and its discharge from industrial wastewaters. TCE volatilizes 
quickly from water depending on temperature, water movement, 
and aeration. The biodégradation of TCE under anaerobic con­
ditions is slow, making TCE relatively persistent in subsurface 
waters. An EPA groundwater survey detected TCE in approxi­
mately 10% of the wells tested. TCE is estimated to be in 34% 
of the nation’s drinking water supplies.
Because of TCE’s volatility, household activities such as bath­
ing, laundering, and cooking with contaminated water may pro­
duce TCE air concentrations above normal ambient levels. Both 
natural and processed foods may contain TCE because of direct 
uptake through the environment, contamination of water used in 
food processing, and contamination by solvents used in clean­
ing food processing equipment. Most processed foods exam­
ined contain levels of a few parts per billion. Studies indicate that 




(1) What are the possible sources of exposure to trichloroethylene for the family described in 
the case study?
Who's at Risk
Workers in metal fabricat­
ing and cleaning opera­
tions have the greatest 
likelihood of exposure to 
high concentrations of 
TCE.
Because TCE inhalation 
can cause euphoria, 
deliberate abuse may 
occur.
Ingestion of alcohol may 
potentiate the CNS depres­
sant effects of TCE.
Most significant exposures to TCE occur in the workplace. The 
National Institute for Occupational Safety and Health (NIOSH) 
has estimated that 3.5 million workers in the United States are 
exposed to TCE, with the majority of high exposures ascribed to 
metal degreasing operations. Sudden death has occurred in 
apparently healthy workers exposed to concentrations exceed­
ing current legal workplace standards and in solvent abusers 
deliberately sniffing typewriter correction fluid from plastic bags 
or in enclosed spaces. Some of these deaths were due to 
asphyxia, whereas others were attributed to either ventricular 
fibrillation or asystole. Although no human studies have directly 
assessed potential dysrhythmogenic effects of TCE, there is no 
evidence that persons exposed to TCE at background environ­
mental concentrations or at allowable workplace levels are at 
increased risk of developing cardiac dysrhythmias.
A small subset of the popu­
lation may be predisposed 
to developing ventricular 
fibrillation or asystole after 
exposure to high concen­
trations of TCE.
Until 1977, when certain uses were banned, TCE was employed 
as an inexpensive, nonflammable, and self-administered obstet­
rical anesthetic (Tri-lene*). It was discovered that alkali in re­
breathing systems could lead to the production of dichloroace- 
tylene, which produced cranial nerve injuries. Workers in envi­
ronments containing this TCE-decomposition product also could 
be at risk of developing trigeminal, optic, or facial nerve effects.
* Use of trade names is for identification only and does not imply endorsement 




Alcohol potentiates TCE's effects on the central nervous sys­
tem. Concurrent alcohol consumption and exposure to TCE can 
result in “degreaser’s flush,” a temporary redness and itching of 
the back, neck, and face. Theoretically, liver dysfunction or 
disulfiram (Antabuse0*) treatment could reduce the metabolism 
of TCE and thus increase its CNS depressant effects.
TCE is one of the volatile organic contaminants most frequently 
found in groundwater. The possibility of an association between 
ingested TCE and long-term effects, including malignancies, 
has been raised, but scientific evidence proving that these 
effects are due to TCE exposure is lacking. To gather informa­
tion on the health effects of ingesting TCE-contaminated water, 
ATSDR, in cooperation with the States, has established a na­
tional registry. This registry is discussed in Sources of Informa­
tion, page 20.
* Use of trade names is for identification only and does not imply endorsement 
by the Public Health Service or the U.S. Department of Health and Human 
Services.
(2) Which members of the family described in the case study are at increased risk for adverse 




□  Pulmonary and gastrointes­
tinal absorption of TCE Is 
rapid; dermal absorption is 
relatively slow.
□  TCE metabolism occurs 
mainly In the liver.
□  Species differences in TCE 
metabolism require that 
caution be used in extrapo­
lating adverse effects to 
humans.
At 100 to 200 ppm TCE, the lungs of human volunteers absorbed 
approximately 50% of an inhaled dose during the first 30 minutes 
of exposure. Case reports of human poisoning after ingestion of 
TCE indicate that gastrointestinal absorption is also substantial. 
Dermal TCE absorption in humans may add to the body burden, 
but toxicity from this source alone is unlikely. In contrast to direct 
contact of the skin with liquid TCE, absorption of its vapor 
through the skin is negligible.
Once absorbed, TCE is rapidly cleared from the blood. Due to 
its lipid solubility, TCE accumulation occurs in organs containing 
high levels of adipose tissue. Data from animal studies indicate 
that body fat, adrenal glands, ovaries, and cellular components 
of the blood accumulate the greatest portion of absorbed TCE. 
TCE rapidly crosses the placenta in both humans and animals, 
and can accumulate in the fetus.
In humans, TCE is metabolized primarily in the liver by the mixed 
function oxidase system that probably converts TCE to an oxide 
(epoxide). Subsequently, this reactive intermediate may re­
arrange to trichloroacetaldehyde and then chloral hydrate, the 
latter forming the trichloroethanol and trichloroacetic acid 
metabolites excreted in the urine after TCE exposure. At 54 to 
140 ppm TCE, human volunteers metabolized approximately 
90% of an inhaled dose. No studies have provided evidence of 
saturation of TCE metabolism in humans, at least for inhaled 
concentrations to 300 ppm.
A relatively small amount of absorbed TCE is exhaled un­
changed; most of an absorbed dose is metabolized and excreted 
in the urine. After exposure to air concentrations between 100 
and 200 ppm, approximately 30% to 50% of an absorbed dose 
appears in urine as trichloroethanol, and about 10% to 30% 
appears as trichloroacetic acid. The time between TCE inhala­
tion and urinary excretion of trichloroethanol is relatively short 
(biologic half-life approximately 10 hours) compared with the 
urinary excretion of trichloroacetic acid (biologic half-life ap­
proximately 52 hours). Trichloroacetic acid is theoretically de­




(3) Additional information for the case study: On the next visit to your office, the mother states 
that some families in their neighborhood are being seen by another practitioner, who has 
sent specimens to a laboratory for measurement o f indicators o f trichloroethylene exposure.
What biologic indicators of TCE exposure are likely being measured?
(4) If biologic measurements are performed, what considerations should be taken into account 
to properly interpret the results?
Physiologic Effects
Studies in humans show that TCE produces CNS effects, mu­
cous membrane, skin, and gastrointestinal irritation, decreased 
appetite, and headache. However, these results are inconsis­
tent with those of better designed studies. Hepatotoxicity has 
been associated primarily with intentional TCE inhalation abuse. 
Renal failure has been reported in concert with confirmed he­
patic damage. Cardiac dysrhythmias due to TCE exposure may 
be induced in susceptible persons.
Central Nervous System Effects
TCE-induced CNS symptoms depend on both concentration and 
exposure duration. In one study of human volunteers, exposure 
to TCE air levels of 27 ppm for 4 hours caused drowsiness and 
mucous membrane irritation, and at 81 ppm, headaches. In 
another study, drowsiness, lethargy, and nausea were noted 
within 5 minutes at anesthetic concentrations of 2000 ppm. TCE 
presumably causes anesthesia by affecting cell membranes and
CNS depression Is the most 




□  Chronic occupational TCE 
exposure has been associ­
ated with neurologic abnor 
malltles.
□  Death due to cardiac
dysrythmia In TCE-exposed 
workers has been associ­
ated with high doses In 
conjunction with vigorous 
physical activity.
□  Case reports associate 
liver damage with inhala­
tion of high doses of TCE.
□  Human nephrotoxicity due 
to TCE exposure is rare 
and generally occurs In 
persons with TCE-lnduced 
hepatic damage.
altering neuronal transmission. Symptoms due to short-term 
exposures typically resolve within a few hours of exposure.
In a study of 50 workers employed from 1 month to 15 years in 
various industrial cleaning and degreasing operations using 
TCE, complaints due to chronic exposure included decreased 
appetite, sleep disturbances, ataxia, vertigo, headache, short­
term memory loss, and fewer word associations. Greater fre­
quency of symptoms were noted in workers exposed to higher 
(85 ppm) than lower (14 ppm) mean TCE concentrations.
In the brains of animals chronically exposed to high concentra­
tions of TCE (1000 ppm to 3000 ppm), histologic changes have 
been demonstrated, but these changes do not correlate with 
behavioral abnormalities detected in animals or humans. Persons 
who have deliberately abused volatile chlorocarbon solvents 
have developed cerebellar damage and ataxia. Electrophysiol- 
ogic studies in humans have not detected significant abnormali­
ties of peripheral nerve conduction.
Cardiovascular Effects
Mortality studies of TCE-exposed workers do not indicate an 
increased risk of cardiovascular death. A few susceptible per­
sons who are exposed to near-anesthetic levels during vigorous 
activity may have increased risk of cardiac dysrythmia. How­
ever, there is no evidence that exposure at high TCE levels 
causes a predisposition to cardiac toxicity at lower levels. When 
TCE was administered as an anesthetic agent, serious ventricu­
lar dysrhythmias and cardiac arrests were rare and were nearly 
always associated with hypoxia. Significant ventricular ectopy 
would not be expected from TCE exposure at background 
environmental levels or those currently allowed in the workplace.
Gastrointestinal and Renal Effects
When swallowed, TCE causes gastrointestinal irritation, with 
possible inflammation of the Gl tract manifested as nausea, 
vomiting, diarrhea, and abdominal pain. Hepatotoxicity has 
been associated primarily with intentional TCE inhalation abuse. 
In these cases, hepatic histologic examination has revealed cen- 
trilobular necrosis with fatty infiltration. Chronic TCE exposures 
at concentrations currently permissible in the workplace or at 
those expected in ambient air are not likely to cause liver dam­
age.
Trichloroethylene Toxicity
TCE-induced renal failure in humans has been reported, albeit 
infrequently, and usually in concert with confirmed hepatic dam­
age. One case involved a long-time metal degreaser who devel­
oped acute tubular necrosis (confirmed by biopsy), which led to 
renal failure. Another case involved a worker exposed to 99.5% 
TCE for 8 hours; he developed allergic interstitial nephritis with 
secondary tubular necrosis. Animals demonstrate little nephro­
toxicity after single, high-dose exposures.
Reproductive and Developmental Effects
No increased incidence of congenital malformations has been 
detected in babies born to mothers occupationally exposed to 
TCE. A small cross-sectional study of degreasing workers showed 
no effect of TCE exposure on male germ cells. Data from animal 
studies reveal no adverse effects on reproductive system histol­
ogy, fertility, or other reproductive performance parameters.
TCE crosses the placenta in animals and has been found in 
human newborns after maternal TCE anesthesia during child­
birth. Human developmental effects were attributed to the 
ingestion of TCE-contaminated water in one study, but the signi­
ficance of this finding is questionable because of mixed chemical 
exposures and methodologic inadequacies of the study. In 
animals, abnormalities (decreased fetal body weight and ossifi­
cation anomalies) have been reported infrequently.
Carcinogenic Effects
Inhalation or oral exposure to high doses of TCE produces liver 
and lung tumors in mice, and renal adenocarcinomas, testicular 
tumors, and possibly leukemia in rats. The relevance of the liver 
tumor data obtained from the mice used in these studies is 
controversial because the species used tends to form spontane­
ous liver tumors. The presence of TCE stabilizers, such as 
epichlorohydrin, may also confound some of these results. 
These studies indicate that mice are more susceptible than rats 
to TCE carcinogenicity.
Most early epidemiologic studies of workplace exposures to 
TCE did not demonstrate a significant increase in the incidence 
of cancer. A recent follow-up study of workers, however, found 
excesses of bladder cancer and lymphomas. The significance of 
this study has yet to be confirmed. Some inconsistencies be­
tween results of animal and human studies may be due to
□  Limited studies in workers 
have not detected signifi­
cant reproductive or devel­
opmental abnormalities due 
to TCE exposure.
□  The few epidemiologic 
studies of TCE-exposed 
persons to determine 




□  TCE is a mild respiratory 
tract irritant and may pro­
duce contact dermatitis.
□  Evidence does not show 
that TCE adversely affects 
the human immune system.
metabolic saturation and formation of reactive intermediates 
that occur in animals exposed to high TCE levels but not in 
humans after low-level exposure.
EPA considers the weight of evidence sufficient to conclude that 
TCE is carcinogenic in animals and a probable human carcino­
gen. However, the animal studies do not meet the National 
Toxicology Program (NTP) guidelines (i.e., positive carcinogen­
icity in multiple species of both sexes); therefore, TCE is not 
listed as a carcinogen in NTP’s most recent report.
Other Effects
TCE produces minimal irritation of the respiratory tract except at 
concentrations exceeding current workplace standards. Use of 
TCE in anesthetic concentrations did not damage the pulmonary 
system. TCE is not a sensitizing agent, and bronchospasm is 
unlikely to occur except in highly susceptible persons after expo­
sure to high concentrations. Rarely are patch tests positive for 
allergic reaction.
Like other organic solvents, TCE may produce contact dermati­
tis, rashes, and burns. The defatting dermatitis resulting from 
prolonged contact may reduce resistance to skin infections. An 
irritant reaction resembling an exfoliative dermatitis orscarlatini- 
form reaction may occur from dermal contact with contaminated 
clothing.
A syndrome called degreaser's flush has been associated with 
the interaction of ingested ethanol and inhaled TCE. Typically, 
erythema resulting from vasodilation develops around the face, 
back, and shoulders within 30 minutes and resolves within an 
hour of appearance.
No deleterious effects on the immune system have been noted 
in persons exposed to TCE through environmental sources. 




(5) Additional information for the case study: The father says that he has fe lt increasingly tired and 
easily fatigued for the past few months. Results o f his physical examination are entirely within 
normal lim its. What tests, if any, would you order?
(6) Additional information: The mother's obstetrician calls 1 month later. Examination, including 
sonogram, is normal for her stage of pregnancy. The obstetrician asks you about the potential 
fetotoxicity of TCE and whether a more invasive evaluation (amniocentesis, chorionic villus 
biopsy) is indicated. What is your response?
Clinical Evaluation
History and Physical Examination
No unique pattern of symptoms characterizes TCE-induced □  TCE exposure produces no 
illness. An occupational history should be routinely obtained and unique clinical clues,
should include items such as company name and location, job 
title, description of chemical processes encountered, known 
toxic agents used, workplace investigations, and coworker 
complaints. An environmental history should also be obtained, 
including location and duration of residence, proximity to indus­
try, diet, daily activities, type of water supply, and use of con­
sumer products that contain TCE.
The patient’s complaints should be identified in terms of onset, 
duration, and intensity. Complaints should be investigated by 
focusing first on organ systems that are likely to be affected by 
exposure to TCE (CNS, hepatic, integumentary), and then on 
systems unlikely to be affected (respiratory, cardiovascular, 
renal, gastrointestinal, endocrine, skeletal). Patients should 
receive a complete neurologic examination, including a mental 
status exam and evaluation of the cranial nerves to detect either
11
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□  Respiratory depression can 
result from acute, hlgh-dose 
TCE exposure.
□  At permissible workplace 
levels, CNS symptoms of 
TCE exposure are usually 
nonspecific and transient.
peripheral or central nervous system involvement. Cranial neu­
ropathies in patients with a history of TCE exposure, while 
uncommon, suggest exposure to dichloroacetylene. Presence 
or absence of an irregular pulse or abnormal cardiac ausculta­
tion should be noted. The patient’s abdomen should be palpated 
for hepatomegaly and right upper quadrant tenderness.
Signs and Symptoms 
Acute Exposure
With inhalation of high concentrations, TCE causes initial CNS 
excitation followed by CNS depression. Depending on the dura­
tion and intensity of exposure, symptoms may be drowsiness, 
dizziness, visual disturbances, lightheadedness, fatigue, head­
ache, lethargy, confusion, ataxia, and stupor. Coma and respi­
ratory depression may occurwith prolonged, high-level exposure 
(i.e., above 2000 ppm). Serious ventricular dysrhythmias can 
develop up to 24 hours after large TCE ingestions.
After any type of acute exposure, the clinician should carefully 
assess the adequacy of ventilation (respiratory depression is the 
most common serious sequelae of acute TCE exposure). Be­
cause of possible dysrhythmias, patients with preexisting car­
diovascular disease should be monitored by continuous ECG 
and frequent evaluation of vital signs. Since hepatic injury may 
occur, liver function tests should be performed.
Chronic Exposure
Reported neurologic effects associated with chronic workplace 
exposure to TCE have included nonspecific symptoms such as 
headache, ataxia, decreased appetite, sleep disturbances, fa­
tigue, weakness, dizziness, memory loss, emotional instability, 
impaired judgment. However, study design defects (e.g., expos- 
sure data that does not allow for differentiation of acute and 
chronic effects, failure to analyze confounding variables, lack of 
controls, and observer bias) limit the conclusion that chronic 
TCE exposure may cause these effects.
Although CNS symptoms may disappear within several weeks 
after cessation of exposure, some health effects may persist in 
persons who have been exposed to TCE for long periods. Per­
sistent neurologic symptoms should also prompt a search for ex­
posure to other potential neurotoxins, such as carbon disulfide, 





Data are limited for interpreting TCE levels in plasma. Detect­
able plasma levels of TCE in persons without occupational 
exposure are approximately 0.01 to 0.13 micrograms per deci­
liter (ng/dL). Although TCE disappears rapidly from the blood, 
metabolites (e.g., trichloroacetic acid) may persist in the blood 
for several weeks and in urine up to 3 weeks after heavy 
exposure. The presence of TCE metabolites should be inter­
preted with caution because medications (chloral hydrate, disul- 
firam) and other chlorinated hydrocarbons (1,1,1-trichloroethane, 
tetrachloroethylene) are also metabolized to trichloroacetic acid 
and excreted in the urine. TCE may appear on abdominal X rays 
as a radiopaque material after ingestion.
Indirect Biologic Indicators
Biochemical abnormalities are uncommon after acute TCE 
exposures. Rarely have elevations of serum hepatic transami­
nases (SGOT or AST, SGPT or ALT), bilirubin, and creatinine 
resulted from acute TCE exposure; nevertheless, liver function 
and serum creatinine tests should be performed to establish 
baselines. Electrocardiogram and continuous cardiac monitor­
ing should be considered for heavily exposed persons. Ingestion 
of large amounts of TCE causing profuse diarrhea may produce 
an electrolyte imbalance. Because the trigeminal, optic, and 
facial nerves may be impaired by exposure to dichloroacetylene, 
changes in the visual fields and trigeminal nerve potentials may 
be noted.
□  TCE may be measured In 
the breath and urine up to 
16 hours after exposure; 
metabolites may persist for 
a week or more.
□  Urinary metabolites are 
trichioroethanol and 
trichloroacetic acid.
□  Liver function tests, a 
serum creatinine test, and 
continuous cardiac 
monitoring should be 
considered for persons 
acutely exposed to TCE.
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(7) Additional information for the case study: You evaluate the 4-year-old child. Review o f 
her history reveals three to four episodes o f otitis media in each of the last 3 years, which 
were treated with ampicillin. The child was placed on continuous prophylactic antibiotics 
during the last two cold seasons. Last year, the child developed additional infections 
despite the antibiotic regimen, and you referred her to an otolaryngologist, who per­
formed a myringotomy and tympanostomy without incident. The mother estimates the 
child has had four episodes of coryza or mild influenza last year, with about 7 days of 
illness that merited staying home from day care.
Does this pattern reflect compromise o f the child's immune system?
(8) The mother asks about immune system tests. A health care practitioner evaluating other 






In the case of dermal contact with liquid TCE, contaminated 
clothes should be removed and the affected areas washed with 
copious amounts of soap and water. Direct eye splashes require 
irrigation for at least 15 minutes. Corneal epithelium damage 
usually resolves spontaneously after irrigation.
Patients should be removed from the contaminated environment 
as soon as possible; begin artificial ventilation, if needed. Those 
with altered mental status or apparent respiratory insufficiency 
should receive supplemental oxygen. If the patient’s pulse is 
absent, cardiopulmonary resuscitation should be initiated.
Gut decontamination (emesis, lavage, saline cathartic) is rec­
ommended if it can be initiated within 2 to 3 hours after ingestion 
of more than a swallow of TCE. However, the effects of these 
measures have not been clinically evaluated. If emesis is consid­
ered, administer the emetic only to patients who are fully con­
scious and have an intact gag reflex. Activated charcoal has not 
been proven to absorb TCE, but in general, effectively de­
creases absorption of most ingested toxic agents. No data are 
available on the ability of hemodialysis or hemoperfusion to 
increase TCE elimination. There are no specific antidotes.
Patients with serious TCE toxicity should be monitored for the 
possible development of dysrhythmias. When diarrhea is pres­
ent, monitorforthe development of electrolyte abnormalities and 
screen forthe possible development of hepatorenal dysfunction. 
Sequelae are unusual with acute exposures.
Chronic Exposure
There is no known treatment for chronic exposure to TCE. 
Potentially involved organ systems should be independently 
evaluated and supportive measures initiated.
□  Removal from the source 
and supportive care Is the 
recommended treatment for 
acute TCE exposure.
□  Symptomatic treatment Is 
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Workplace 
Air
In 1989, the Occupational Safety and Health Administration 
(OSHA) lowered the permissible exposure limit (PEL) from a 
time-weighted average (TWA) of 100 ppm to 50 ppm, with 
200 ppm TCE as a short-term exposure limit (STEL). The TWA 
concentration for a normal 8-hour workday and 40-hour work­
week is set at a level at which nearly all workers may be 
repeatedly exposed without adverse effects. The STEL for TCE 
is a concentration at which workers can be exposed continu­
ously for a short period of time (usually 15 minutes) without suf­
fering irritation, chronic irreversible tissue damage, or narcosis. 
NIOSH recommends a 10-hour TWA of 25 ppm. Table 1 summa­
rizes current standards and regulations for TCE exposure.
Table 1. Standards and regulations for trichloroethylene
Agency Focus Level Comments
ACGIH Air -Workplace 50 ppm Advisory; TWA^
NIOSH Air -Workplace 25 ppm Advisory; TWA^
OSHA Air -Workplace 50 ppm 
200 ppm
Regulation; PEL§over 8-hour 
workday
Regulation; STEL5
EPA Air-Environment N/A Under review
Drinking Water 5 ppb Regulation
* ACGIH = American Conference of Governmental Industrial Hygienists; EPA = Environmental 
Protection Agency; NIOSH = National Institute for Occupational Safety and Health; OSHA = 
Occupational Safety and Health Administration
t TWA (Time-Weighted Average) = time-weighted average concentration for a normal 8-hour 
workday and 40-hour workweek to which nearly all workers may be repeatedly exposed.
§ PEL (Permissible Exposure Limit) = highest level of trichloroethylene in air, averaged over an 
8-hour workday, to which a worker may be exposed.
?STEL (Short-Term Exposure Limit) = usually determined by a 15-minute sampling period.




Biologic exposure indices are recommended by the American 
Conference of Governmental Industrial Hygienists and may in­
volve either direct or indirect measures of individual worker ex­
posure. An end-exhaled air sample collected 16 hours after the 
last TCE exposure (i.e., priorto the next shift) should be 0.4 ppm 
or less. Free trichloroethanol in the blood may be measured, but 
a number of other compounds affect the level of trichloroethanol 
and must be considered as alternate explanations for elevated 
levels.
Alternatively, a concentration of 100 milligrams (mg) of trichloro­
acetic acid per liter (L) of urine at the end of the work week 
reflects the upper biologic limit for TCE exposure. Urinary 
trichloroacetic acid levels can be increased by the same com­
pounds that affect blood trichloroethanol levels. Because of 
large individual variations, this urinary trichloroacetic acid level 
of 100 mg/L should be used only as a “warning” level or mean 
for a group of workers.
Environment
Environmental exposures to TCE are generally low and are de­
creasing since limitations have been imposed on its use as an 
anesthetic, solvent extractant, fumigant, and dry-cleaning agent. 
TCE has a short atmospheric half-life (less than 7 days) and 
does not accumulate in the food chain. The World Health 
Organization recommended drinking water limit is 30 |ig TCE/L 
of water (30 ppb); EPA recommends a maximum contaminant 
level of 5 |xg/L (5 ppb) in drinking water. Based on the available 
data, no known human health effects are associated with expo­
sures to environmental levels of TCE, but more comprehensive 
information is necessary for a final assessment.
(9) TCE has been identified as the irritant at the day-care center. The mother described in the case 
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Answers to Pretest and Challenge Questions_________
Pretest
Pretest is found on page 1.
(a) The mother’s problem list includes pregnancy and anxiety; and the child’s, frequent otitis media (status 
post myringotomy and tympanostomy tube placement) and frequent upper respiratory infections.
(b) You will need information on TCE toxicity, including reproductive and developmental effects; informa­
tion on TCE contamination of the family’s drinking water, including duration of contamination; copies 
of information provided to the family by the municipal water company; and responses, if any, from local 
and state health agencies.
(c) None of the symptoms described in the case indicates serious illness. However, you should reassure 
the family that you will perform complete physical examinations with appropriate testing at the next visit. 
In response to concern about the child’s infections, you should indicate that you will collect information 
about possible TCE effects on the immune system. Explain to the parents that tests of immune function 
are often difficult to interpret and may not be appropriate. You may indicate that you will consult sources 
of information on TCE’s effects on pregnancy. It is important to maintain a balance between 
reassurance that the unborn child is probably not affected by the water contamination and concern for 
the possible risk to the fetus. Reassurance should not, however, appear to trivialize the family’s fears. 
It would also be appropriate to discuss that no evaluation, however thorough, can totally exclude the 
possibility that a person may develop an illness, including cancer.
Challenge
Challenge questions begin on page 4.
(1) Possible sources of the family’s TCE exposure include home drinking water (dermal and inhalation 
exposure during bathing, and ingestion), father’s workplace (inhalation), and the daughter’s day-care 
center (inhalation). Minor sources might be certain foods such as margarine (ingestion) and use of TCE- 
containing consumer products such as correction fluid, spot removers, etc. (inhalation).
(2) From the information about the family thus far, none of them fits the profile of a person at increased risk 
from the effects of TCE exposure. That is, there is no indication that any family member has liver 
dysfunction or cardiac disorders, abuses TCE, or consumes large amounts of alcohol.
(3) The most convenient biologic indicators of TCE exposure are the urinary metabolites, trichloroethanol 
and trichloroacetic acid. These metabolites are not specific to TCE, however, since they are also 
metabolites of tetrachloroethylene (perchloroethylene) and 1,1,1-trichloroethane (methyl chloroform) 
and certain medications. TCE itself can be measured directly in blood or exhaled air, but because of 
the difficulty of obtaining samples, such measurements are not indicated here.
(4) To properly interpret any of the tests mentioned in (3), a knowledge of the time-lapse between exposure 
and collection is necessary. To prevent contamination or sample loss (evaporation, adsorption), the 
proper collection, handling, storage, and transportation procedures must be followed. It is unlikely that 
any member of this family would have levels of TCE or its metabolites significantly above background 




(5) No further studies are indicated for TCE exposure. A workup for fatigue may indicate additional tests.
(6) Based on limited evidence from animal studies, researchers believe teratogenicity does not occur at 
environmental TCE levels. Invasive procedures are not justified on the basis of the drinking water 
contamination.
(7) No, a recent survey of infections in children under 3 years of age over a September to March period 
found an average of 2.5 total infections and more than one episode of otitis media per child (1.4 
episodes per child for those in day care). Over 3% of the children in day care were hospitalized for 
tympanostomies. (Reference: Bell DM, Gleiber DW, Mercer AA, et al. Illness associated with child day 
care: a study of incidence and cost. Am J Public Health 1989;79:479-84.) The child described in the 
case study appears to have an above-average rate of infections, but they are not frequent enough to 
suggest immunologic impairment.
(8) No, immunocompetence tests are not appropriate because no evidence of immune function abnormali­
ties has been found in similar situations. Nevertheless, physicians may be asked to explain further why 
they are not performing the tests on their patients. Two references that may be of value are (1) Kahn E, 
Letz G. Clinical ecology:environmental medicine or unsubstantiated theory? Ann Intern Med 1989; 
2:104-6; and (2) American College of Physicians. Clinical ecology. Ann Intern Med 1989;2:168-78.
If it had been indicated, laboratory evaluation of immunologic host-defense defects would consist of 
three phases. The preliminary screening is a complete blood count with differential smear and 
quantitative immunoglobulin levels. These tests, together with history and physical examination, will 
identify more than 95% of patients with primary immunodeficiencies. The second phase of testing 
consists of readily available studies including B-cell function (such as antibodies, response to 
immunization), T-cell function (skin tests, contact sensitization), and complement levels. The first two 
phases combined will detect most immunodeficiencies amenable to conventional treatment with 
gamma globulin or plasma. The third phase (in-depth investigation) consists of testing induction of 
B lymphocyte differentiation in vitro, stimulated by pokeweed mitogen and histologic and immunofluor- 
escent examination of biopsy specimens; T-cell surface markers; assays of T-cell helper or killer cell 
functions; and functional assays using appropriate target cells. It is inappropriate to perform these latter 
tests on environmentally exposed patients except for epidemiologic research.
Primary immunodeficiency is suspected in an infant who has repeated upper respiratory tract or other 
infections. It is also suspected if repeated infection occurs in a child who has had little exposure to 
infectious agents, or any child with unusual infections, incomplete clearing of infections, growth failure, 
hepatosplenomegaly, or features associated with specific immunodeficiency disorders, such as ataxia 
or telangiectasia. The child described in the case study has none of these indications.
(9) EPA has not issued an emission standard for TCE. Assuming discussions with the owner or operator 
of the shop adjacent to the day-care center have not been effective in reducing the level of ambient TCE, 
the community’s air pollution control center should be notified. States may allow this control under the 
jurisdiction of local air pollution control districts, county health departments, or other local agencies. 
The agency responsible for enforcement of air standards should be contacted to investigate possible 
release of TCE onto the day-care center property.
Sources of Information
In addition to other resources, ATSDR has created a National Exposure Registry for trichloroethylene. This 
registry is the first in a series of registries mandated by the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980 (CERCLA). ATSDR, in cooperation with the States, will establish 
and maintain national registries of (1 ) persons exposed to substances and (2) persons with serious illness
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or diseases possibly due to exposure. The registries will collect information on the effects of low-level 
exposures of long duration (the exposures typically found in populations surrounding hazardous waste 
sites) and the health outcomes for populations receiving a one-time, high-level environmental exposure 
(such as those experienced at chemical spill sites). The registries will facilitate the identification and 
subsequent tracking of persons exposed to a defined substance at selected sites and will coordinate the 
clinical and research activities involving the registrants. For further information on the trichloroethylene 
registry, please contact ATSDR in Atlanta, Georgia.
More information on the adverse effects of trichloroethylene and the treatment and management of trichlo- 
roethylene-exposed persons can be obtained from ATSDR, your state and local health departments, and 
university medical centers. Case Studies in Environmental Medicine: Trichloroethylene Toxicity is one of 
a series. For other publications in this series, please use the order form on the back cover. For clinical 
inquiries, contact ATSDR, Division of Health Education, Office of Director, at (404) 639-6204.
Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding CME credits and CEUs is a posttest score of 70% or better.
The Centers for Disease Control (CDC) is accredited by the Accreditation Council for Continuing Medical Education 
(ACCME) to sponsor continuing medical education for physicians, and by the International Association for 
Continuing Education and Training (IACET) to sponsor continuing education units for other health professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 credit hour 
of continuing medical education (CME) credit in category 1 of the Physician's Recognition Award of the American 
Medical Association and 0.1 hour of continuing education units (CEU) for other health professionals upon 
completion of this monograph.
This program has been reviewed and is acceptable for 1 prescribed hour by the American Academy of Family 
Physicians (term of approval: beginning January 1992). For specific information, please consult the AAFP Office 
of Continuing Medical Education.
The American College of Emergency Physicians (ACEP) has approved this program for 1 hour of ACEP Category 
1 credit.
The American Osteopathic Association (AOA) has approved this program for 1 credit hour of Category 2-B AOA- 
CME credit.
To receive continuing education credit (CME or CEUs), complete the Posttest on page 22 in the manner shown 
in the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?
After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEUs will also be forwarded 
to participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 









Circle all correct answers and transfer your answers to page 23.






2. Chronic exposure to TCE may
a. cause headaches or drowsiness
b. mildly alter liver function
c. cause short-term memory deficits
d. cause Alzheimer’s disease
e. result in Gilbert’s syndrome
3. Laboratory tests to confirm TCE exposure include
a. blood analysis for trichloroethanol
b. breath analysis for trichloroacetic acid
c. urinary creatine
d. cardiac isoenzymes
e. urinary trichloroacetic acid






e. upper respiratory tract and eye irritation
5. Drinking water contaminated with low levels of TCE has been conclusively associated with
a. trigeminal neuralgia
b. cardiac ventricular dysrhythmias
c. hepatorenal syndrome
d. no specific pathology
e. cleft palate in children born to exposed pregnant women
6. Cardiac toxicity due to TCE exposure
a. is a frequent cause of death among dry-cleaning workers
b. has not caused increased mortality among metal degreasers
c. is caused by the metabolism of TCE to carbon monoxide
d. may lead to dysrhythmias
e. may be due to arteriosclerosis





e. milk of magnesia
8. Likelihood of TCE exposure exists for
a. accountants
b. automobile parts manufacturers
c. judges
d. electronic workers
e. race car drivers
— A t s d r __________________________________________________________________ _
22
Trichloroethylene Toxicity
CASE STUDIES IN ENVIRONMENTAL MEDICINE: TRICHLOROETHYLENE
If you wish CME credits or CEUs, please indicate your answers to the Posttest questions on page 22 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency forToxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, Atlanta, 
GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by circling your response.
1 • Was the breadth of information in this issue sufficient for your needs?
Yes No Undecided
2. Was the amount of detail appropriate?
Too technical Just right Not technical enough
3. As a result of reading this issue, will you now ask patients more questions regarding possible 
environmental exposures?
Yes No Undecided Not applicable
4. Would you recommend this issue to your colleagues?
Yes No Undecided









□  CME-AMA □  CME-AMA □  CME-ACEP □  CME-AOA 
I I CEU □  Contact Hours
Specialty__________________________________________________







Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Check the Case Studies in Environmental Medicine that you wish to have sent to you.
ta arsenic □ dioxins □ tetrachloroethylene
□ asbestos a lead □ 1,1,1-trichloroethanea benzene □ mercury □ trichloroethylene
□ beryllium □ methanol □ toluenea cadmium a methylene chloride a vinyl chloridea carbon tetrachloride □ nitrates/nitrites a Exposure History
□ chlordane a phenols □ Risk Communicationa Cholinesterase inhibitors □ polyaromatic hydrocarbons (PAHs) a Skin Diseasesa chromium a polychlorinated biphenyls (PCBs)
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The state of knowledge regarding the treatment of patients potentially exposed to 
hazardous substances in the environment is constantly evolving and is often 
uncertain. In this monograph, the Agency for Toxic Substances and Disease 
Registry (ATSDR) has made diligent effort to ensure the accuracy and currency 
of the information presented but makes no claim that the document comprehensively 
addresses all possible situations related to this substance. This monograph is 
intended as an additional resource for physicians and other health professionals 
in assessing the condition and managing the treatment of patients potentially 
exposed to hazardous substances. It is not, however, a substitute for the 
professional judgment of a health care provider and must be interpreted in light 
of specific information regarding the patient available to such a professional and 
in conjunction with other sources of authority.
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